Therapy-enhancing glucan

Immunologically modified carbon nanotubes for cancer treatment

Biomarkers for prostate cancer and methods for their detection

Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin

Immunoadjuvant compounds and uses thereof

NOVEL IMMUNOGENS AND METHODS FOR DISCOVERY AND SCREENING THEREOF

Formulations which stabilize and inhibit precipitation of immunogenic compositions

Human respiratory syncytial virus vaccine

IMMUNOGENIC COMPOSITIONS USEFUL IN PROVOKING AN INTEGRATED RESPONSE TO TUMOR ANTIGENS

Immunogenic LHRH compositions and methods relating thereto

ZWITTERIONIC IMMUNOMODULATORS FOR THE TEATMENT OF ASTHMA AND ALLERGY

Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals

Adjuvanted rabies vaccine with improved viscosity profile

Oral pharmaceutical composition

Molecular vaccines for infectious disease

Saponin adjuvant compositions and methods relating thereto

Immunologically modified carbon nanotubes for cancer treatment

Vaccine composition

Synergistic combination of honokiol and modified citrus pectin in cancer therapy

Adjuvant composition containing poly-gamma-glutamic acid-chitosan nanoparticles

Adjuvanting meningococcal factor H binding protein

Scaffolds for cell transplantation

COMPOSITION FOR PREVENTION AND TREATMENT OF ALLERGIC AND/OR INFLAMMATORY DISEASES

PREVENTATIVE OR THERAPEUTIC AGENT AND METHOD FOR IMMUNE DISEASE

Oral vaccine fast-dissolving dosage form using starch

Non-aqueous synthesis of polysaccharide-protein conjugates for vaccines

ADJUVANTING MENINGOCOCCAL FACTOR H BINDING PROTEIN

INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES

Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish

SOLID DISPERSING VACCINE COMPOSITION FOR ORAL DELIVERY

Protein Complex and Process for Producing the Same

NOVEL, NON-ANTIGENIC, MUCOSAL ADJUVANT FORMULATION WHICH MODULATES THE EFFECTS OF SUBSTANCES, INCLUDING VACCINE ANTIGENS, IN CONTACT WITH MUCOSAL BODY SURFACES

Inactivated dengue virus vaccine with aluminium-free adjuvant

Vaccines for Pandemic Influenza

Pharmaceutical composition comprising an antigen

Encapsulated vaccines for the oral vaccination and boostering of fish and other animals

Influenza virus-like particles (VLPS) comprising hemagglutinin

IMMUNOGENIC LHRH COMPOSITIONS AND METHODS RELATING THERETO

VEHICLE FOR DELIVERING A COMPOUND TO A MUCOUS MEMBRANE AND RELATED COMPOSITIONS, METHODS AND SYSTEMS

Vaccine preparation for neospora caninum infection

COMPOSITION COMPRISING CHITOSAN FOR OCULAR ADMINISTRATION OF VACCINE(S) TO AVIANS

Vaccine Composition

Non-digestible sugar-coated products and process

MUCOSAL VACCINE USING CATIONIC NANOGEL

Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity

Therapy-enhancing glucan

Method of conferring a protective immune response to norovirus

Immunomodulating compositions and methods of use thereof

NOVEL FORMULATIONS WHICH STABILIZE AND INHIBIT PRECIPITATION OF IMMUNOGENIC COMPOSITIONS

CARBOHYDRATE FUNCTIONALIZED CATANIONIC SURFACTANT VESICLES FOR DRUG DELIVERY

MUCOSAL COMBINATION VACCINES FOR BACTERIAL MENINGITIS

MUCOADHESIVE PARTICULATE FORMULATION FOR INDUCING ANTIGEN-SPECIFIC IMMUNE TOLERANCE

MUCOSAL MENINGOCOCCAL VACCINES

Nutritional Composition for Improving the Mammalian Immune System

Immunologically active compositions

Recombinant Rhinovirus Vectors

Arabinogalactan for enhancing the adaptive immune response

POLYPEPTIDES COMPRISING EPITOPES OF HIV GP41 AND METHODS OF USE

Tannin-chitosan composites

ZWITTERIONIC IMMUNOMODULATORS FOR THE TREATMENT OF ASTHMA AND ALLERGY

Vaccine for treatment and prevention of herpes simplex virus infection

VACCINE

for dust mite allergy

Normuramyl glycopeptide compounds

SOLID DISPERSING VACCINE COMPOSITION FOR ORAL DELIVERY

Synthetic archaeal glycolipid adjuvants

RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ

Pharmaceutical composition of tacrolimus

Detoxification method for lipopolysaccharide (LPS) or lipid A of gram-negative bacteria

IMMUNOTHERAPY COMPOSITIONS, METHOD OF MAKING AND METHOD OF USE THEREOF

PROCESSES OF MAKING NORTH AMERICAN GINSENG FRACTIONS, PRODUCTS CONTAINING THEM, AND USE AS IMMUNOMODULATORS

ADJUVANTED GLUCANS

Oral pharmaceutical composition

INFLUENZA VIRUS-LIKE PARTICLES (VLPS) COMPRISING HEMAGGLUTININ PRODUCED WITHIN A PLANT

Anthrax carbohydrates, synthesis and uses thereof

THERAPY-ENHANCING GLUCAN

METHOD FOR DELIVERING A HUMAN CHORIONIC GONADOTROPIN (Hcg) VACCINE FOR LONG-ACTING ANTIBODY PROTECTION

Pharmaceutical cyclosporin compositions

Pharmaceutical Composition Containing the NMB1796 Protein

Methods for increasing the diversity of monoclonal antibodies produced against an antigen

COMPOSITIONS AND METHODS FOR CHITOSAN ENHANCED IMMUNE RESPONSE

VACCINE

Chimeric influenza virus-like particles

IMMUNOLOGICAL COMPOSITION

Flu vaccine admixture of mannan and flu antigen

Chitin micro-particles as an adjuvant

Use of zwitterionic polysaccharides for the specific modulation of immune processes

Immunogenic LHRH compositions and methods relating thereto

Immunoadjuvant

Methods of producing microparticles

NON-DIGESTIBLE SUGAR-COATED PRODUCTS AND PROCESS

Anthrax carbohydrates, synthesis and uses thereof

Encapsulated vaccines for the oral vaccination and boostering of fish and other animals

Immunogenic LHRH compositions and methods relating thereto

Compositions comprising chitin microparticles and their medical uses

Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site

Composition Comprising a Colloidal Synthetic Bioresorbable Vector and a Viral Vector

Pharmaceutical Composition Comprising An Antigen

Composition and method for treating autoimmune disease and mucosal disorder

Method of making immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane

Method of inducing an immune response in a host by administering immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane

IMMUNE RESPONSE ENHANCING GLUCAN

Immunizing compositions comprising recombinant attenuated self-replicating viral RNA replicons encoding an epitope obtained from the HIV-1 matrix protein myrstate binding site

Enhancement of immune response to vaccine by interferon alpha

Methods and Compositions for Immunizing Pigs Against Porcine Circovirus

VACCINES

Processes of making north american ginseng fractions, products containing them, and use as immunomodulators

Herbal mixture extract of rehmanniae radix preparata and acanthopanacis cortex and a composition comprising the same for prevention and treatment of osteoporosis

Immunoactive Compositions for Improved Oral Delivery of Vaccines and Therapeutic Agents

Destruction of spores through glycoconjugate enhanced phagocytosis

THERAPY-ENHANCING GLUCAN

Human endogenous retrovirus polypeptide compositions and methods of use thereof

Method of extensive culture of antigen-specific cytotoxic T cells

FORMULATIONS USEFUL FOR IMMUNOTHERAPY FOR CANCERS CONTAINING BACTERIAL COMPONENT AS AN ACTIVE INGREDIENT

VACCINES

VLP-antigen conjugates and their uses as vaccines

VACCINE COMPOSITION

Polycationic Carbohydrates as Immunostimulants in Vaccines

Scaffolds for cell transplantation

Herbal mixture extract of preparata and and a composition comprising the same for prevention and treatment of osteoporosis

SOLID DISPERSING VACCINE COMPOSITION FOR ORAL DELIVERY

IRIDOID GLYCOSIDE COMPOSITION

Formulations which stabilize and inhibit precipitation of immunogenic compositions

Immunomodulating compositions and uses therefor

Mucosal meningococcal vaccines

Anthrax antigens and methods of use

Synthetic polysaccharide antigens for immunological intervention in disease

Gene expression vaccine

Composition and method for treating autoimmune disease and mucosal disorder

Alkyl-glycoside enhanced vaccination

Therapy-enhancing glucan

Delivery vehicles, bioactive substances and viral vaccines

Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs

Mucosal combination vaccines for bacterial meningitis

Methods for increasing the diversity of monoclonal antibodies produced against an antigen

Compositions with enhanced immunogenicity

In situ maturation of dendritic cells

Allergy vaccine composition, production method thereof and use of same in allergy treatment

Mucosal vaccines with chitosan adjuvant and meningococcal antigens

Immunogenic LHRH compositions and methods relating thereto

Therapy-enhancing glucan

Immunoadjuvant

Dry formulation for transcutaneous immunization

Molecules enhancing dermal delivery of influenza vaccines

Immunotherapy compositions, method of making and method of use thereof

Apparatus and method for transdermal delivery of influenza vaccine

Immunogenic composition and method of developing a vaccine based on fusion protein

Immunizing compositions encoding an epitope obtained from the HIV-1 capsid protein cyclophilin A binding site

Processes of making north american ginseng fractions, products containing them, and use as immunomodulators

Pharmaceutical composition comprising an antigen

Molecules enhancing dermal delivery of influenza vaccines

Immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) devoid of CD55 and CD59 in the viral membrane

Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide

Immunogenic composition and method of developing a vaccine based on factor H binding sites

Adjuvanted influenza vaccine

Delivery of physiological agents with in-situ gels comprising anionic polysaccharides

Vaccines